Literature DB >> 9616151

A 5' regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells.

A Petrella1, I Doti, V Agosti, P C Giarrusso, D Vitale, H M Bond, C Cuomo, P Tassone, B Franco, A Ballabio, S Venuta, G Morrone.   

Abstract

The recently-identified Wiskott-Aldrich syndrome protein gene (WASP) is responsible for the Wiskott-Aldrich X-linked immunodeficiency as well as for isolated X-linked thrombocytopenia (XLT). To characterize the regulatory sequences of the WASP gene, we have isolated, sequenced and functionally analyzed a 1.6-Kb DNA fragment upstream of the WASP coding sequence. Transfection experiments showed that this fragment is capable of directing efficient expression of the reporter chloramphenicol acetyltransferase (CAT) gene in all human hematopoietic cell lines tested. Progressive 5' deletions showed that the minimal sequence required for hematopoietic-specific expression consists of 137 bp upstream of the transcription start site. This contains potential binding sites for several hematopoietic transcription factors and, in particular, two Ets-1 consensus that proved able to specifically bind to proteins present in nuclear extracts of Jurkat cells. Overexpression of Ets-1 in HeLa resulted in transactivation of the CAT reporter gene under the control of WASP regulatory sequences. Disruption of the Ets-binding sequences by side-directed mutagenesis abolished CAT expression in Jurkat cells, indicating that transcription factors of the Ets family play a key role in the control of WASP transcription.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616151

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.

Authors:  Alexander Astrakhan; Blythe D Sather; Byoung Y Ryu; Socheath Khim; Swati Singh; Stephanie Humblet-Baron; Hans D Ochs; Carol H Miao; David J Rawlings
Journal:  Blood       Date:  2012-03-19       Impact factor: 22.113

2.  High-mobility group A1 proteins are overexpressed in human leukaemias.

Authors:  Giovanna Maria Pierantoni; Valter Agosti; Monica Fedele; Heather Bond; Irene Caliendo; Gennaro Chiappetta; Francesco Lo Coco; Fabrizio Pane; Maria Caterina Turco; Giovanni Morrone; Salvatore Venuta; Alfredo Fusco
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

3.  Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models.

Authors:  Francesco Marangoni; Marita Bosticardo; Sabine Charrier; Elena Draghici; Michela Locci; Samantha Scaramuzza; Cristina Panaroni; Maurilio Ponzoni; Francesca Sanvito; Claudio Doglioni; Marie Liabeuf; Bernard Gjata; Marie Montus; Katherine Siminovitch; Alessandro Aiuti; Luigi Naldini; Loïc Dupré; Maria Grazia Roncarolo; Anne Galy; Anna Villa
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

Review 4.  Development of lentiviral gene therapy for Wiskott Aldrich syndrome.

Authors:  Anne Galy; Maria-Grazia Roncarolo; Adrian J Thrasher
Journal:  Expert Opin Biol Ther       Date:  2008-02       Impact factor: 4.388

5.  Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors.

Authors:  Pilar Muñoz; Miguel G Toscano; Pedro J Real; Karim Benabdellah; Marién Cobo; Clara Bueno; Verónica Ramos-Mejía; Pablo Menendez; Per Anderson; Francisco Martín
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

6.  Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome.

Authors:  M Catucci; F Prete; M Bosticardo; M C Castiello; E Draghici; M Locci; M G Roncarolo; A Aiuti; F Benvenuti; A Villa
Journal:  Gene Ther       Date:  2011-12-22       Impact factor: 5.250

7.  UMG Lenti: novel lentiviral vectors for efficient transgene- and reporter gene expression in human early hematopoietic progenitors.

Authors:  Emanuela Chiarella; Giovanna Carrà; Stefania Scicchitano; Bruna Codispoti; Tiziana Mega; Michela Lupia; Daniela Pelaggi; Maria G Marafioti; Annamaria Aloisio; Marco Giordano; Giovanna Nappo; Cristina B Spoleti; Teresa Grillone; Emilia D Giovannone; Raffaella Spina; Francesca Bernaudo; Malcolm A S Moore; Heather M Bond; Maria Mesuraca; Giovanni Morrone
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

Review 8.  The identification of hematopoietic-specific regulatory elements for WASp gene expression.

Authors:  Jun Zhan; Irudayam Maria Johnson; Matthew Wielgosz; Arthur W Nienhuis
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-14       Impact factor: 6.698

9.  Safe and Effective Gene Therapy for Murine Wiskott-Aldrich Syndrome Using an Insulated Lentiviral Vector.

Authors:  Swati Singh; Iram Khan; Socheath Khim; Brenda Seymour; Karen Sommer; Matthew Wielgosz; Zachary Norgaard; Hans-Peter Kiem; Jennifer Adair; Denny Liggitt; Arthur Nienhuis; David J Rawlings
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-18       Impact factor: 6.698

Review 10.  The WASP and WAVE family proteins.

Authors:  Shusaku Kurisu; Tadaomi Takenawa
Journal:  Genome Biol       Date:  2009-06-15       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.